Dwarfism and early death in mice lacking C-type natriuretic peptide

被引:354
作者
Chusho, H
Tamura, N
Ogawa, Y [1 ]
Yasoda, A
Suda, M
Miyazawa, T
Nakamura, K
Nakao, K
Kurihara, T
Komatsu, Y
Itoh, H
Tanaka, K
Saito, Y
Katsuki, M
Nakao, K
机构
[1] Kyoto Univ, Sch Med, Dept Med & Clin Sci, Kyoto 6068507, Japan
[2] Suntory Inst Biomed Res, Shimamoto, Osaka 6180024, Japan
[3] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo 1080071, Japan
关键词
D O I
10.1073/pnas.071389098
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Longitudinal bone growth is determined by endochondral ossification that occurs as chondrocytes in the cartilaginous growth plate undergo proliferation, hypertrophy, cell death, and osteoblastic replacement. The natriuretic peptide family consists of three structurally related endogenous ligands, atrial, brain, and C-type natriuretic peptides (ANP, BNP, and CNP), and is thought to be involved in a variety of homeostatic processes. To investigate the physiological significance of CNP in vivo, we generated mice with targeted disruption of CNP (Nppc(-/-) mice). The Nppc(-/-) mice show severe dwarfism as a result of impaired endochondral ossification. They are all viable perinatally, but less than half can survive during postnatal development. The skeletal phenotypes are histologically similar to those seen in patients with achondroplasia, the most common genetic form of human dwarfism. Targeted expression of CNP in the growth plate chondrocytes can rescue the skeletal defect of Nppc(-/-) mice and allow their prolonged survival. This study demonstrates that CNP acts locally as a positive regulator of endochondral ossification in vivo and suggests its pathophysiological and therapeutic implication in some forms of skeletal dysplasia.
引用
收藏
页码:4016 / 4021
页数:6
相关论文
共 32 条
  • [1] CHINKERS M, 1991, ANNU REV BIOCHEM, V60, P553, DOI 10.1146/annurev.biochem.60.1.553
  • [2] CHRISMAN TD, 1993, J BIOL CHEM, V268, P3698
  • [3] DIFFERENTIAL EXPRESSION OF NATRIURETIC PEPTIDE GENES IN CARDIAC AND EXTRACARDIAC TISSUES
    DAGNINO, L
    DROUIN, J
    NEMER, M
    [J]. MOLECULAR ENDOCRINOLOGY, 1991, 5 (09) : 1292 - 1300
  • [4] HOWELL DS, 1992, DISSORDERS BONE MINE
  • [5] Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3)
    Jaubert, J
    Jaubert, F
    Martin, N
    Washburn, LL
    Lee, BK
    Eicher, EM
    Guénet, JL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) : 10278 - 10283
  • [6] GENETIC DECREASES IN ATRIAL-NATRIURETIC-PEPTIDE AND SALT-SENSITIVE HYPERTENSION
    JOHN, SWM
    KREGE, JH
    OLIVER, PM
    HAGAMAN, JR
    HODGIN, JB
    PANG, SC
    FLYNN, TG
    SMITHIES, O
    [J]. SCIENCE, 1995, 267 (5198) : 679 - 681
  • [7] SELECTIVE ACTIVATION OF THE B-NATRIURETIC PEPTIDE RECEPTOR BY C-TYPE NATRIURETIC PEPTIDE (CNP)
    KOLLER, KJ
    LOWE, DG
    BENNETT, GL
    MINAMINO, N
    KANGAWA, K
    MATSUO, H
    GOEDDEL, DV
    [J]. SCIENCE, 1991, 252 (5002) : 120 - 123
  • [8] C-TYPE NATRIURETIC PEPTIDE (CNP) IN RATS AND HUMANS
    KOMATSU, Y
    NAKAO, K
    SUGA, S
    OGAWA, Y
    MUKOYAMA, M
    ARAI, H
    SHIRAKAMI, G
    HOSODA, K
    NAKAGAWA, O
    HAMA, N
    KISHIMOTO, I
    IMURA, H
    [J]. ENDOCRINOLOGY, 1991, 129 (02) : 1104 - 1106
  • [9] PHYSIOLOGICAL-ROLE OF SILENT RECEPTORS OF ATRIAL-NATRIURETIC-FACTOR
    MAACK, T
    SUZUKI, M
    ALMEIDA, FA
    NUSSENZVEIG, D
    SCARBOROUGH, RM
    MCENROE, GA
    LEWICKI, JA
    [J]. SCIENCE, 1987, 238 (4827) : 675 - 678
  • [10] The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system
    Matsukawa, N
    Grzesik, WJ
    Takahashi, N
    Pandey, KN
    Pang, S
    Yamauchi, M
    Smithies, O
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) : 7403 - 7408